Table 1.

Demographic and clinical data from human subjects.

Control (n = 29)STEMI (n = 28)P-value
Age, years64 (53–67)65 (57–73)0.506
Female11 (37.9)5 (17.9)0.092
Ethnicity—White29 (100)28 (100)>0.999
Height, cm167.8 ± 8.5168.0 ± 6.70.947
Weight, kg80.0 (73.0–87.5)77.5 (70.0–88.5)0.856
BMI, kg/m−228.4 (27.2–30.1)28.3 (25.6–29.6)0.854
CV risk
 Type 2 diabetes mellitus7 (24.1)6 (21.4)0.808
 Arterial hypertension24 (82.8)15 (53.6)0.018a
 Dyslipidemia24 (82.8)18 (64.3)0.113
 Active smoker10 (34.5)15 (53.6)0.147
 Previous CAD0 (0)5 (17.9)0.017a
 Chronic kidney disease0 (0)5 (17.9)0.017a
CCU admission
 Troponin I, ng/mlN/a25.8 (4.2–54.9)
 Peak troponin I, ng/mlN/a65.0 (24–117.0)
 NT-proBNP, pg/mlN/a488.5 (180.8–1,642.0)
 C-reactive protein, mg/dlN/a1.1 (0.3–2.9)
 Serum creatinine, mg/dlN/a0.9 (0.8–1.3)
 Hemoglobin, g/dlN/a13.44 ± 2.03
  • Values are median (interquartile range), n (%) or mean ± SD; BMI, body mass index; CV, cardiovascular; CAD, coronary artery disease; CCU, coronary care unit; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; N/a, non-applicable.

  • a Adjusted P-value < 0.05.